$SIBN

PISETSKY MICHAEL A. sold $52K of SIBN

PISETSKY MICHAEL A. (SVP, Ops & Adm/Chief Legal Ofr) sold 3,134 shares of SI-BONE, Inc. (SIBN) at an average of $16.71 ($16.70–$16.86) across 3 trades on 2026-07-02.

Original reporting
SEC EDGAR · PISETSKY MICHAEL A.
Published Jul 6, 2026, 9:11 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 6, 2026, 9:16 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SIBN
Neutral
medium confidence
Mentioned
$SIBN
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SIBNNeutralLow
01

Why it matters

This adds incremental information about insider activity (open-market sale by an SVP/Chief Legal Officer) but does not introduce new operational or financial guidance.

02

Market read

Traders may monitor insider activity for sentiment, but the filing alone is unlikely to drive a durable repricing without accompanying company-specific catalysts.

03

What to watch

Transaction size ($52.4K) is relatively small versus typical institutional flows, and the article provides no follow-on insider buys or concurrent operational news.

Relevance 3/10Novelty 3/10Timing: Filed 2026-07-06 after-hours; reflects sale executed 2026-07-02.

Background

The article is a SEC Form 4 insider transaction disclosure for SI-BONE, Inc. (SIBN).

Company-level read

Ticker impact

$SIBNNeutralMedium confidence
Context

SI-BONE insider Michael A. Pisetsky sold $52.4K of SIBN shares in an open-market transaction on 2026-07-02.

Expected impact

Likely limited/short-lived impact; any reaction would be sentiment-driven rather than earnings- or guidance-driven.

Evidence & confidence

The filing discloses transaction size ($52.4K) and role, but provides no new company performance, guidance, or legal/operational development.

Market effects

None—this is company-specific insider transaction data, not a sector-wide signal.

None.

None.

Counterpoint

The sale could be for diversification, taxes, or planned liquidity needs; without a 10b5-1 plan, it still may not indicate negative fundamentals.

Key entities

  • SI-BONE, Inc.

    Company whose insider transaction is disclosed via Form 4.

  • Michael A. Pisetsky

    SVP, Ops & Adm / Chief Legal Officer who sold shares.

Related articles

$SIBNHigh

SI-BONE, Inc. (SIBN): Results of Operations and Financial Condition

SI-BONE, Inc. (SIBN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991_q226earningsrel.htm EX-99.1 Document Exhibit 99.1 SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance Delivered ~15% WW revenue growth and ~178% increase in adjusted EBITDA ~19% increase in U.S. physician base Second Q